Form 8-K - Current report:
SEC Accession No. 0001104659-24-071787
Filing Date
2024-06-14
Accepted
2024-06-14 16:27:58
Documents
13
Period of Report
2024-06-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417321d1_8k.htm   iXBRL 8-K 27997
  Complete submission text file 0001104659-24-071787.txt   201543

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA knsa-20240614.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20240614_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20240614_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417321d1_8k_htm.xml XML 3693
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 241045255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)